460 related articles for article (PubMed ID: 26214546)
1. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
[TBL] [Abstract][Full Text] [Related]
2. Use of RBC deformability index as an early marker of diabetic nephropathy.
Lee SB; Kim YS; Kim JH; Park K; Nam JS; Kang S; Park JS; Shin S; Ahn CW
Clin Hemorheol Microcirc; 2019; 72(1):75-84. PubMed ID: 30452406
[TBL] [Abstract][Full Text] [Related]
3. Association of reduced red blood cell deformability and diabetic nephropathy.
Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
[TBL] [Abstract][Full Text] [Related]
4. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
Kacso IM; Kacso G
Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
[TBL] [Abstract][Full Text] [Related]
6. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cystatin C- and creatinine-based estimation of glomerular filtration rate according to glycaemic status in Type 2 diabetes.
Oh SJ; Lee JI; Ha WC; Jeong SH; Yim HW; Son HS; Sohn TS
Diabet Med; 2012 Jul; 29(7):e121-5. PubMed ID: 22414167
[TBL] [Abstract][Full Text] [Related]
9. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Hasslacher C; Kulozik F
J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
[TBL] [Abstract][Full Text] [Related]
11. Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes.
Chung SM; Oh JH; Moon JS; Kim YK; Yoon JS; Won KC; Lee HW
Sci Rep; 2018 Jan; 8(1):908. PubMed ID: 29343776
[TBL] [Abstract][Full Text] [Related]
12. Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy.
Kuo CW; Chen HL; Tu MY; Chen CM
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F32-F41. PubMed ID: 30303710
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
Takashima H; Yoshida Y; Nagura C; Furukawa T; Tei R; Maruyama T; Maruyama N; Abe M
Diab Vasc Dis Res; 2018 Sep; 15(5):469-472. PubMed ID: 29923427
[TBL] [Abstract][Full Text] [Related]
14. A comparison of GFR by modified gates method with measured creatinine clearance rate (CCR) & MDRD formula based estimation in type 2 diabetic subjects with nephropathy.
Haque MF; Iqbal MM; Ahmed Z; Sultan T; Rahman M; Quddus S; Rahman MQ; Ahmed NN
Mymensingh Med J; 2013 Oct; 22(4):655-60. PubMed ID: 24292292
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
17. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
19. New and old markers of progression of diabetic nephropathy.
Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
Li Vecchi M; Fuiano G; Francesco M; Mancuso D; Faga T; Sponton A; Provenzano R; Andreucci M; Tozzo C
Nephron Clin Pract; 2007; 105(2):c62-7. PubMed ID: 17135770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
